Sotorasib, sold under the brand names Lumakras and Lumykras, is an anti-cancer drug, it for the treatment of KRAS G12C mutant non small cell lung cancer, colorectal cancer, and appendix cancer. Reference standards of Sotorasib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Sotorasib
Catalogue No.:PA 19 2200000
CAS :
Molecular Formula : C30H30F2N6O3
Molecular Weight : 560.61
4-((R)-4-Acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one
Catalogue No.:PA 19 2201000
4-((S)-4-Acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one
Catalogue No.:PA 19 2201001
Sotorasib Metabolite M10
Catalogue No.:PA 19 2201002
Molecular Formula : C33H37F2N7O5S
Molecular Weight : 681.76
Sotorasib Metabolite M18
Catalogue No.:PA 19 2201003
Molecular Formula : C30H30F2N6O4
Molecular Weight : 576.6
Sotorasib Metabolite M24
Catalogue No.:PA 19 2201004
Molecular Formula : C22H18F2N4O3
Molecular Weight : 424.41
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
